PROCEPT BioRobotics Corp. (PRCT)
21.60
+0.35
(+1.65%)
USD |
NASDAQ |
Aug 25, 16:00
21.58
-0.02
(-0.09%)
After-Hours: 19:59
PROCEPT BioRobotics Free Cash Flow : -84.92M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -84.92M |
| March 31, 2026 | -80.57M |
| December 31, 2025 | -58.34M |
| September 30, 2025 | -79.73M |
| June 30, 2025 | -89.27M |
| March 31, 2025 | -88.21M |
| December 31, 2024 | -103.62M |
| September 30, 2024 | -103.56M |
| Date | Value |
|---|---|
| June 30, 2024 | -109.24M |
| March 31, 2024 | -126.17M |
| December 31, 2023 | -133.21M |
| September 30, 2023 | -125.74M |
| June 30, 2023 | -122.38M |
| March 31, 2023 | -106.02M |
| December 31, 2022 | -83.04M |
| September 30, 2022 | -73.80M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Insulet Corp. | 265.70M |
| Globus Medical, Inc. | 750.84M |
| Abbott Laboratories | 7.824B |
| Alphatec Holdings, Inc. | -5.739M |
| Artivion, Inc. | -9.157M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -19.25M |
| Cash from Investing (Quarterly) | -2.953M |
| Cash from Financing (Quarterly) | 4.496M |
| Free Cash Flow Per Share (Quarterly) | -0.3891 |
| Free Cash Flow to Equity (Quarterly) | -21.71M |
| Free Cash Flow to Firm (Quarterly) | -21.36M |
| Free Cash Flow Yield | -6.98% |